GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Price-to-Free-Cash-Flow

Cryosite (ASX:CTE) Price-to-Free-Cash-Flow

: 20.92 (As of Today)
View and export this data going back to 2002. Start your Free Trial

As of today (2024-04-19), Cryosite's share price is A$0.795. Cryosite's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.04. Hence, Cryosite's Price-to-Free-Cash-Flow Ratio for today is 20.92.

The historical rank and industry rank for Cryosite's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:CTE' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.86   Med: 20.96   Max: 345
Current: 20.92

During the past 13 years, Cryosite's highest Price-to-Free-Cash-Flow Ratio was 345.00. The lowest was 2.86. And the median was 20.96.

ASX:CTE's Price-to-Free-Cash-Flow is ranked better than
70.33% of 91 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.86 vs ASX:CTE: 20.92

Cryosite's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$0.04.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Cryosite was 280.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 42.20% per year.

During the past 13 years, Cryosite's highest 3-Year average Free Cash Flow per Share Growth Rate was 43.90% per year. The lowest was -141.00% per year. And the median was 23.10% per year.


Cryosite Price-to-Free-Cash-Flow Historical Data

The historical data trend for Cryosite's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 16.25 200.00 18.53 27.17

Cryosite Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 18.53 - 27.17 -

Competitive Comparison

For the Diagnostics & Research subindustry, Cryosite's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryosite Price-to-Free-Cash-Flow Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Cryosite's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cryosite's Price-to-Free-Cash-Flow falls into.



Cryosite Price-to-Free-Cash-Flow Calculation

Cryosite's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.795/0.038
=20.92

Cryosite's Share Price of today is A$0.795.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryosite's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Cryosite  (ASX:CTE) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Cryosite Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Cryosite's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Cryosite (ASX:CTE) Business Description

Traded in Other Exchanges
N/A
Address
13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142
Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Cryosite (ASX:CTE) Headlines

No Headlines